Authors: Doolittle, ND Muldoon, LL Brummett, RE Tyson, RM Lacy, C Bubalo, JS Kraemer, DF Heinrich, MC Henry, JA Neuwelt, EA

Citation: Nd. Doolittle et al., Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors, CLIN CANC R, 7(3), 2001, pp. 493-500

Authors: Muldoon, LL Walker-Rosenfeld, SL Hale, C Purcell, SE Bennett, LC Neuwelt, EA

Citation: Ll. Muldoon et al., Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants, J PHARM EXP, 296(3), 2001, pp. 797-805

Authors: Neuwelt, EA Pagel, MA Hasler, BP Deloughery, TG Muldoon, LL

Citation: Ea. Neuwelt et al., Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administrationof alkylators, with or without glutathione depletion in a rat model, CANCER RES, 61(21), 2001, pp. 7868-7874

Authors: Muldoon, LL Pagel, MA Kroll, RA Brummett, RE Doolittle, ND Zuhowski, EG Egorin, MJ Neuwelt, EA

Citation: Ll. Muldoon et al., Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity, CLIN CANC R, 6(1), 2000, pp. 309-315

Authors: Doolittle, ND Miner, ME Hall, WA Siegal, T Hanson, EJ Osztie, E McAllister, LD Bubalo, JS Kraemer, DF Fortin, D Nixon, R Muldoon, LL Neuwelt, EA

Citation: Nd. Doolittle et al., Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors, CANCER, 88(3), 2000, pp. 637-647

Authors: Muldoon, LL Pagel, MA Kroll, RA Roman-Goldstein, S Jones, RS Neuwelt, EA

Citation: Ll. Muldoon et al., A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery, AM J NEUROR, 20(2), 1999, pp. 217-222